New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery

1 publisher first detected Oct 21, 2026 2% of 46 Health publishers

Headline as filed by Medical Xpress.

Compare coverage — 1 report

Every publisher that filed on this event, earliest first, with each one's headline, summary, times and how long after the first report they filed.
Publisher	Headline	Summary	Published	Detected	Delay	Source	Status
Medical Xpress	New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery	Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug Administration (FDA) on Monday approved the immunotherapy Jemperli (dostarlimab-gxly)	21 Oct, 01:20	21 Oct, 01:30	0m	medicalxpress.com	First

Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.

Reader comments

Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.

Nobody has commented on this story yet.

New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery

Compare coverage — 1 report

Reader comments

Add a comment

Related coverage

Recalled butter sold in 10 states receives risk warning: FDA

FDA patient, consumer reps often tied to pharma-funded groups

Medical device adverse event reports are often incomplete, inaccurate and delayed

FDA may allow some toxic chemicals to be added to food without safety review. Experts are alarmed